These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32014568)

  • 1. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population.
    Chandler SF; Chu E; Whitehill RD; Bevilacqua LM; Bezzerides VJ; DeWitt ES; Alexander ME; Abrams DJ; Triedman JK; Walsh EP; Mah DY
    Heart Rhythm; 2020 Jun; 17(6):984-990. PubMed ID: 32014568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
    Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
    J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
    Paul T; Lehmann C; Pfammatter JP; Kallfelz HC
    Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
    Agusala K; Oesterle A; Kulkarni C; Caprio T; Subacius H; Passman R
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):490-8. PubMed ID: 25626340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
    Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
    J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early experience with intravenous sotalol in children with and without congenital heart disease.
    Valdés SO; Miyake CY; Niu MC; de la Uz CM; Asaki SY; Landstrom AP; Schneider AE; Rusin CG; Patel R; Lam WW; Kim JJ
    Heart Rhythm; 2018 Dec; 15(12):1862-1869. PubMed ID: 30003959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of sotalol (Darob) therapy in supraventricular tachyarrhythmias.
    Toporan D; Protopopescu T; Ioan A; Paraschiv A
    Rom J Intern Med; 1998; 36(3-4):207-17. PubMed ID: 10822517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.
    Saul JP; Schaffer MS; Karpawich PP; Erickson CC; Epstein MR; Melikian AP; Shi J; Karara AH; Cai B; Hinderling PH
    J Clin Pharmacol; 2001 Jan; 41(1):35-43. PubMed ID: 11144992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Sotalol in the Young: Safe and Effective Treatment With Standardized Protocols.
    Borquez AA; Aljohani OA; Williams MR; Perry JC
    JACC Clin Electrophysiol; 2020 Apr; 6(4):425-432. PubMed ID: 32327076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
    Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
    Am J Cardiol; 2017 May; 119(9):1366-1370. PubMed ID: 28283175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of initiating therapy with sotalol for treatment of atrial fibrillation.
    Marcus FI
    J Am Coll Cardiol; 1998 Jul; 32(1):177-80. PubMed ID: 9669267
    [No Abstract]   [Full Text] [Related]  

  • 13. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
    Price JF; Kertesz NJ; Snyder CS; Friedman RA; Fenrich AL
    J Am Coll Cardiol; 2002 Feb; 39(3):517-20. PubMed ID: 11823091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
    Sung RJ; Tan HL; Karagounis L; Hanyok JJ; Falk R; Platia E; Das G; Hardy SA
    Am Heart J; 1995 Apr; 129(4):739-48. PubMed ID: 7900626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome.
    Tanel RE; Walsh EP; Lulu JA; Saul JP
    Am Heart J; 1995 Oct; 130(4):791-7. PubMed ID: 7572588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose sotalol in pediatric arrhythmia therapy.
    Rokicki W; Dukalska M
    Pediatr Cardiol; 1999; 20(2):172-3. PubMed ID: 9986903
    [No Abstract]   [Full Text] [Related]  

  • 17. Sotalol prophylaxis was efficient and safe for supraventricular tachycardia in early infancy.
    Evertsson C; Eliasson H; Halvorsen CP
    Acta Paediatr; 2024 Nov; 113(11):2430-2437. PubMed ID: 39073535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sotalol in treatment of pediatric cardiac arrhythmias.
    Celiker A; Ayabakan C; Ozer S; Ozme S
    Pediatr Int; 2001 Dec; 43(6):624-30. PubMed ID: 11737739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M
    Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias.
    Knudson JD; Cannon BC; Kim JJ; Moffett BS
    Pediatr Cardiol; 2011 Oct; 32(7):896-903. PubMed ID: 21553267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.